association with cardiovascular morbidity and mortality. However, whether or not there is a sex difference in the association of serum uric acid level with LV mass has never been systematically explored. We examined the sex-specific relation of serum uric acid level and echocardiographic indexes of LV structure in never-treated patients with essential hypertension. We enrolled 160 never-treated hypertensive patients (89 men and 71 women) to assess the possible relationship between LV mass and serum uric acid levels. LV measurements were performed according to the recommendations of the American Society of Echocardiography and the Penn Convention. LV mass was indexed by height, body surface area and height raised to the 2.7th power. A positive significant correlation between LV geometry (LV mass, indexed LV mass and relative wall thickness) and serum uric acid level was found in male hypertensive patients but not in female hypertensive patients. Independent determinants of serum uric acid levels in male hypertensive patients were LV mass and serum creatinine levels. In addition, male hypertensive patients with concentric hypertrophy showed the highest serum uric acid levels. In comparison, independent determinants of serum uric acid levels in female hypertensive patients were age and serum creatinine levels. In conclusion, these findings indicate a sex difference in the association of uric acid with LV geometry in Japanese hypertensive patients. In addition, the finding that the highest levels of serum uric acid were observed in our male hypertensive patients with concentric hypertrophy confirmed the previous reports that these patients have the highest risk for cardiovascular morbidity and mortality. (Hypertens Res 2005; 28: 133-139)
Introduction
Many epidemiological studies have suggested that serum uric acid is a risk factor for cardiovascular disease (1−7). Elevated serum uric acid levels are accompanied by obesity, dyslipidemia, hypertension and insulin resistance, and all of which are also associated with increased risk for cardiovascular disease (8) . The Chicago Industry Heart Study (4), a prospective 11.5-year study of 2,400 industrial workers, found serum uric acid levels to be independently associated with increased cardiovascular morbidity and mortality, but only in women. In Japan, there is a report suggesting a significant correlation between elevated serum uric acid levels and cardiovascular risk factors in large members of men, but not women (5) . While sex-related differences in the impact of elevated serum uric acid levels on future cardiovascular disease have been reported, the sex-related specific role of serum uric acid in relation to cardiovascular disease has been unclear.
Echocardiographically determined left ventricular (LV) hypertrophy is known to be a powerful, independent risk factor of future cardiovascular morbidity and mortality in patients with uncomplicated essential hypertension as well as the general population (9−12) . Furthermore, there is increasing evidence of a link between LV hypertrophy and hypertensive target organ damage (13−15) . An association of increased LV mass with adverse outcomes has been consistently reported in men and women, but the question of whether or not the relative strength of the relation of serum uric acid level to LV mass is similar in the two sexes has never been systematically explored. Accordingly, we examined the sex-specific relation of serum uric acid level and echocardiographic indexes of LV structure in never-treated patients with essential hypertension.
Methods

Study Population
One hundred and sixty never-treated patients (89 men and 71 women) with uncomplicated essential hypertension were enrolled in the study. Patients were excluded who had a preexisting cardiac disease, a pre-existing medical illness, such as diabetes mellitus, or M-mode echocardiograms inadequate for clearly detecting the internal lines of the interventricular septum and LV posterior wall. Sixty-four age-and sexmatched normotensive subjects (35 men and 29 women) who had no history of hypertension and no evidence of cardiac disease served as controls. All study subjects participated in this study after giving informed consent. The study was carried out in accordance with the Declaration of Helsinki (1989) of the World Medical Association.
Physical Examinations
Weight and height were measured while the subjects were fasting overnight and wearing only underwear. Body mass index (BMI) was calculated as weight (kg) divided by [height (m)]
2 . Blood pressure was measured in triplicate by a single physician who was expert in the evaluation of hypertension, with an appropriate arm cuff and a mercury sphygmomanometer after 5 min of rest in the sitting position. The arithmetic mean of the last two measurements was calculated. Korotkoff phase V was taken for diastolic blood pressure. Hypertension was defined as a blood pressure above 140/90 mmHg, according to the classification of BP for adults in the Guideline for the Management of Hypertension for General Practitioners (JSH 2000) (16) .
Biochemical Measurements
In the morning, after an overnight fast, venous blood was sampled for the measurement of serum uric acid, serum creatinine, and serum concentrations of total cholesterol (TC), high density lipoprotein (HDL) cholesterol and triglycerides (TG). Uric acid was analyzed by the uricase-peroxidase method. Normal serum uric acid levels in our laboratory are 4.3−8.0 mg/dl for men, and 2.7−5.8 mg/dl for women. Creatinine was analyzed by Jaffe's method (normal range in our laboratory: 0.5−1.2 mg/dl). The 24-h urine collections for creatinine clearance in hypertensive patients were supervised by the nursing staff. The 24-h creatinine clearance was taken as an index of glomerular filtration rate. Measurements of serum creatinine, urinary creatinine, serum uric acid, TC, HDL cholesterol and TG were carried out using an automatic analyzer (model TBA-60S; Toshiba Inc., Tokyo, Japan).
Echocardiographic Measurements
Two-dimensionally guided M-mode echocardiography was performed by standard methods, as previously outlined (17) using an SSD-870 or SSD-5500 echocardiograph with a 3.5 MHz transducer (Aloka Inc., Tokyo, Japan). LV internal dimension (LVID) and interventricular septal thickness (IVST) and posterior wall thickness (PWT) were measured at end-diastole and end-systole, according to the American Data are presented as the mean±SD. LV, left ventricular; BSA, body surface area; ns, not significant. (18), and used for all purposes except determination of LV mass. LV mass was calculated at end-diastole by using the Penn convention (19) . LV mass/height, LV mass/body surface area (BSA) and LV mass/ height 2.7 were calculated as indexed LV mass. Relative wall thickness (RWT) was calculated as 2 ×(PWTd/LVIDd), where d is end-diastole. Percent fractional shortening (FS) was calculated as (LVIDd -LVIDs)/LVIDd × 100 and was used as an indicator of LV systolic function, where d and s are end-diastole and end-systole, respectively. Aortic annular cross-sectional area (in cm 2 ) was calculated from the measured aortic annulus and multiplied by the aortic time-velocity integral in cm to yield Doppler stroke volume (SV) (20) .
Society of Echocardiography guidelines
Subgroups Analysis
On the basis of the relationship between RWT and LV mass/ BSA, 89 male and 71 female hypertensive patients were then divided into 4 different groups, respectively. The partition values of 0.44 for RWT and 108 g/m 2 (male) or 104 g/m 2 (female) for LV mass/BSA, the mean+2SD value of normotensive control subjects, were used. The groups consisted of male hypertensive patients with normal RWT and LV mass/ BSA (normal geometry; n= 31, 35%); patients with concentric remodeling (n= 5, 6%); patients with concentric hypertrophy (n= 22, 24%); and patients with eccentric hypertrophy (n= 31, 35%). Furthermore, the groups consisted of female hypertensive patients with normal RWT and LV mass/BSA (normal geometry; n= 27, 38%); patients with concentric remodeling (n= 5, 7%); patients with concentric hypertrophy (n= 12, 17%); and patients with eccentric hypertrophy (n= 27, 38%).
Statistical Analysis
All values are expressed as the mean ±SD. 
Results
Hemodynamic and Echocardiographic Characteristics
Office systolic blood pressure, diastolic blood pressure or pulse pressure was significantly higher in hypertensive patients than that in normotensive control subjects. LV mass/ BSA and RWT were also larger in hypertensive patients than those in normotensive control subjects. Although Doppler stroke volume did not differ significantly, percent fractional shortening in hypertensive patients was lower than that in normotensive control subjects (Table 1) .
Sex-Related Differences in Hemodynamic and Echocardiographic Characteristics
There were no significant differences in age, heart rate, systolic blood pressure, diastolic blood pressure and pulse pressure between male and female hypertensive patients. Although LV mass/BSA in male hypertensive patients was larger than that in female hypertensive patients, RWT and Doppler stroke volume did not differ significantly. Furthermore, percent fractional shortening in female hypertensive patients was higher than that in male hypertensive patients ( Table 2) .
Sex-Related Differences in Biochemical Characteristics
Although there was no significant difference in the 24-h crea tinine clearance between male and female hypertensive patients, serum uric acid and serum creatinine levels in male hypertensive patients were significantly higher than those in female hypertensive patients. Both total and HDL cholesterol levels in female hypertensive patients were significantly higher than those in male hypertensive patients. There were no significant differences in BMI and TG levels between the male and female hypertensive groups (Table 3) .
Correlations between Serum Uric Acid Levels and LV Geometry or Serum Lipid Levels
As shown in Table 4 , serum uric acid levels were significantly related to LV mass, LV mass/height, LV mass/BSA, LV mass/height 2.7 and RWT in male hypertensive patients. However, serum uric acid levels were not significantly related to LV geometry (LV mass, indexed LV mass and RWT) in female hypertensive patients. Serum uric acid levels were not significantly related to percent FS in either male or female hypertensive patients. Furthermore, serum uric acid levels were not significantly related to BMI, TC, HDL cholesterol or TG levels in either male or female hypertensive patients. Table 5 shows the results of multiple regression analysis. Independent determinants of serum uric acid levels in male hypertensive patients were LV mass and serum creatinine levels. In contrast, independent determinants of serum uric acid levels in female hypertensive patients were age and serum creatinine levels. In addition, Fig. 1A shows the comparison of serum uric acid levels in male hypertensive patients with normal geometry (6.1±1.1 mg/dl), concentric remodeling (6.9±1.6 mg/dl), concentric hypertrophy (7.5±1.2 mg/dl) and eccentric hypertrophy (6.8±1.5 mg/dl). Male hypertensive patients with concentric hypertrophy showed the highest serum uric acid levels. However, there were no significant correlations between serum uric acid levels and LV geometry in female hypertensive patients. Figure 1B shows the comparison of serum uric acid levels in female hypertensive patients with normal geometry (5.1±0.9 mg/dl), concentric remodeling (5.7 ± 1.3 mg/dl), concentric hypertrophy (5.2±1.2 mg/ dl) and eccentric hypertrophy (5.8±1.1 mg/dl).
Discussion
In this cross-sectional study, serum uric acid levels correlated positively with LV geometry (LV mass, indexed LV mass and RWT) in male hypertensive patients, but not in female hypertensive patients. In comparison, serum uric acid levels correlated positively with age in female hypertensive patients, but not in male hypertensive patients. These findings indicate a sex difference in the association of uric acid with LV geome- try in Japanese hypertensive patients. At least two prior investigations that performed sex-specific analyses reported an association of hyperuricemia with increased cardiovascular morbidity and mortality in women but not men (4, 21) . In contrast, one previous report has suggested a significant correlation between hyperuricemia and cardiovascular risk factors in large members of men, but not women in Japan (5) . Furthermore, it is well recognized that increased LV mass is an independent predictor for cardiovascular morbidity and mortality in both men and women. Our results provide the first evidence that serum uric acid levels in male hypertensive patients are positively correlated with echocardiographic LV mass but not in female hypertensive patients. The present data also demonstrate that when we classify male hypertensive patients on the basis of their pattern of LV geometry, the highest serum uric acid levels are evident in patients with concentric hypertrophy.
Our clinical study design did not enable us to clearly state why serum uric acid levels are correlated with LV mass only in male hypertensive patients. However, our data are consistent with Japanese epidemiological evidence that hyperuricemia may be associated with increased cardiovascular events in men, but not in women (5) . Thus, our findings add further support to the concept that serum uric acid level is a sensitive indicator of the future cardiovascular events in Japanese male patients with hypertension. However, it should be emphasized that the serum uric acid levels reported in this study were derived from fasting blood. It is well recognized that serum uric acid levels in humans have circadian rhythm. Elevated serum uric acid levels accentuate after ingestion of a HT, hypertension; LV, left ventricular; BP, blood pressure.
Fig. 1. Comparison of the serum uric acid levels in male (A) and female (B) hypertensive patients with normal geometry, concentric remodeling, concentric hypertrophy and eccentric hypertrophy. Column height represents the mean; bars indicate 95% confidence intervals.
high-protein meal or alcohol intake, but not after a low-protein meal. Thus, fasting levels may not adequately reflect the effect of uric acid on coronary circulation. Different indexes of LV mass have been proposed for normalization of mass for body size (9, 22, 23) . The optimal index, if a generalizable one exists, is still undefined, and the use of differing indexes in the literature can cause confusion. In the present study, the use of 3 different indexes of LV mass, which were normalized LV mass for body size resulted in no significant differences in the major findings.
Age was an independent predictor for the elevation of serum uric acid level in female hypertensive patients. The relation between age and the occurrence of hyperuricemia differed between men and women. Hyperuricemia correlated negatively with age in men but positively with age in women (5, 24, 25) . In our study, a positive correlation between serum uric acid level and age was also recognized in female hypertensive patients. Interactions of sex hormones have been suggested as a possible cause of the difference in correlation between serum uric acid level and age in men and women (4) . Furthermore, the LV wall thickness and LV mass have been shown to significantly increase with advancing age in healthy normotensive subjects (26, 27) . Therefore, the absence of an association between serum uric acid level and LV mass in female hypertensive patients in the present study may have been due to the small sample size.
In the early stage of hypertension, the serum uric acid level increases as renal blood flow decreases without affecting the glomerular filtration rate (28) . Therefore, it certainly is possible that uric acid may be an earlier and more sensitive marker of decreased renal blood flow than serum creatinine. Furthermore, there is increasing evidence that hyperuricemia is associated with a multimetabolic syndrome (29) in which insulinmediated renal hemodynamic abnormalities lead to hypertensive renal damage (30, 31) . Facchini et al. (32) have suggested that resistance to insulin-mediated glucose uptake and/or the compensatory hyperinsulinemia associated with a multimetabolic syndrome decrease urinary uric acid clearance, with a subsequent elevation of serum uric acid level. One of the limitations in our study was the lack of information on potentially important characteristics such as fasting plasma glucose and insulin level. Unfortunately, we could not determine the impact of insulin resistance on hyperuricemia in our study.
Despite the wealth of evidence that serum uric acid level is associated with a number of metabolic abnormalities, the relationship between serum uric acid level and the severity of hypertension is not yet fully understood. In our study, multivariate analysis revealed that serum creatinine level is an independent predictor of serum uric acid level in both male and female hypertensive patients. However, in all study patients, serum creatinine levels were within normal limits. Further investigations are needed to identify whether serum creatinine is merely a marker for renal dysfunction or plays a causative role in the incidence of hyperuricemia. An elevated serum uric acid level may reflect impaired endothelial integrity, in which the endothelial-dependent vascular relaxation produced by nitric oxide is reduced. In addition, activation of the renin-angiotensin-aldosterone system in patients with essential hypertension plays important roles in the pathogenesis of myocardial hypertrophy (33) and the elevation of serum uric acid level. These processes contribute to the evolution of atherosclerosis (34, 35) . The association between LV mass and serum uric acid level, as reported in our study, provides a potential and earlier pathophysiological link to explain the increased risk of vascular events in hypertensive patients with LV hypertrophy. Both LV hypertrophy and elevated serum uric acid in hypertensive patients may be considered indicative of preclinical cardiovascular disease that may be reversed by the effective therapeutic interventions (36−38). Verdecchia et al. reported that the decrease in LV mass brought about by antihypertensive therapy is associated with a reduced risk for subsequent events (36) . Furthermore, the decreasing of uric acid by allopurinol in patients with diabetes mellitus and congestive heart failure has been shown to result in improved endothelial-dependent vasodilatation (37) . Thus, the finding that hyperuricemia and LV hypertrophy may be reversed by a pharmacological treatment may suggest a new target for therapeutic intervention in essential hypertension.
Finally, a previous prospective study has demonstrated that patients with concentric hypertrophy have a higher incidence of cardiovascular events than patients with other types of LV geometry (10) . In the present study, the finding that the highest levels of serum uric acid were observed in our male hypertensive patients with concentric hypertrophy confirms the previous reports that these patients have the highest risk for cardiovascular morbidity and mortality (9−12) .
